CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-10 | WEST MICHAEL D Co-Chief Executive Officer | Shares withheld for taxes | −541 | $2.20 | $1K | 886,758 |
| 2018-07-10 | WEST MICHAEL D Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −1,562 | 10,938 | ||
| 2018-07-10 | MOHANTY ADITYA P. Co-Chief Executive Officer | Option exercise | +4,687 | 103,005 | ||
| 2018-07-10 | MOHANTY ADITYA P. Co-Chief Executive Officer | Shares withheld for taxes | −1,621 | $2.20 | $4K | 101,384 |
| 2018-07-10 | MOHANTY ADITYA P. Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −4,687 | 32,813 | ||
| 2018-07-01 | KINGSLEY ALFRED D See Remarks | Grant or award · Option to Purchase Common Shares | +70,000 | 70,000 | ||
| 2018-07-01 | Russell Angus C. Director | Grant or award · Option to Purchase Common Shares | +40,000 | 40,000 | ||
| 2018-07-01 | Redmond Cavan M. Director | Grant or award · Option to Purchase Common Shares | +40,000 | 40,000 | ||
| 2018-07-01 | Mulroy Michael H. Director | Grant or award · Option to Purchase Common Shares | +40,000 | 40,000 | ||
| 2018-07-01 | FARRELL STEPHEN C Director | Grant or award · Option to Purchase Common Shares | +40,000 | 40,000 | ||
| 2018-07-01 | ANDREWS DEBORAH J Director | Grant or award · Option to Purchase Common Shares | +40,000 | 40,000 | ||
| 2018-07-01 | BRADSHER NEAL C Director | Grant or award · OPTION TO PURCHASE COMMON SHARES | +40,000 | 40,000 | ||
| 2018-04-10 | WEST MICHAEL D Co-Chief Executive Officer | Option exercise | +1,563 | 886,278 | ||
| 2018-04-10 | WEST MICHAEL D Co-Chief Executive Officer | Shares withheld for taxes | −541 | $2.49 | $1K | 885,737 |
| 2018-04-10 | WEST MICHAEL D Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −1,563 | 12,500 | ||
| 2018-04-10 | MOHANTY ADITYA P. Co-Chief Executive Officer | Option exercise | +4,688 | 99,940 | ||
| 2018-04-10 | MOHANTY ADITYA P. Co-Chief Executive Officer | Shares withheld for taxes | −1,622 | $2.49 | $4K | 98,318 |
| 2018-04-10 | MOHANTY ADITYA P. Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −4,688 | 37,500 | ||
| 2018-03-15 | Patton Stephana Eilene General Counsel & Secretary | Grant or award · Option to Purchase Common Shares | +125,000 | 125,000 | ||
| 2018-03-15 | SKIBSTED RUSSELL Chief Financial Officer | Grant or award · Option to Purchase Common Shares | +150,000 | 150,000 |
Page 14 of 17 · 322 trades